TEVA-BETAMETHASONE/ CALCIPOTRIOL
TEVA-BETAMETHASONE/ CALCIPOTRIOL
Approved
DIN Number
02427419
Drug Class
Human
Market Date
Aug 7, 2020
Company
HC
teva canada limited
Product Information
Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.
Product Details
Health Canada regulatory and product classification information
Regulatory Identifiers
DIN Number02427419
AIG Number0252270001
Classification & Schedule
C
Drug Class
Human
S
Schedule
Prescription
A
ATC Code
D07XC01 BETAMETHASONE
Product Specifications
Dosage FormOintment
Route of AdministrationTopical
AHFS Classification84:92.00
Health Canada Classification
ACTIVE INGREDIENTS (2)
BETAMETHASONE (BETAMETHASONE DIPROPIONATE)Active
Strength: 0.5 MG / G
Monograph: BETAMETHASONE (BETAMETHASONE DIPROPIONATE)
CALCIPOTRIOLActive
Strength: 50 MCG / G
Monograph: CALCIPOTRIOL